Oasmia Pharmaceutical Ab Stock Five Year Return
Oasmia Pharmaceutical AB fundamentals help investors to digest information that contributes to Oasmia Pharmaceutical's financial success or failures. It also enables traders to predict the movement of Oasmia Pink Sheet. The fundamental analysis module provides a way to measure Oasmia Pharmaceutical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Oasmia Pharmaceutical pink sheet.
Oasmia |
Oasmia Pharmaceutical AB Company Five Year Return Analysis
Oasmia Pharmaceutical's Five Year Return is considered one of the best measures to evaluate fund performance, especially from the mid and long term perspective. It shows the total annualized return generated from holding equity for the last five years and represents capital appreciation of the investment, including all dividends, losses, and capital gains distributions.
More About Five Year Return | All Equity Analysis
Five Year Return | = | (Mean of Monthly Returns - 1) | X | 100% |
Although Five Year Returns can give a sense of overall investment potential, it is recommended to compare equity performance with similar assets for the same five year time interval. Similarly, comparing overall investment performance over the last five years with the appropriate market index is a great way to determine how this equity instrument will perform during unforeseen market fluctuations.
CompetitionAccording to the company disclosure, Oasmia Pharmaceutical AB has a Five Year Return of 0.0%. This indicator is about the same for the Healthcare average (which is currently at 0.0) sector and about the same as Drug Manufacturers—Specialty & Generic (which currently averages 0.0) industry. This indicator is about the same for all United States stocks average (which is currently at 0.0).
Oasmia Five Year Return Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Oasmia Pharmaceutical's direct or indirect competition against its Five Year Return to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Oasmia Pharmaceutical could also be used in its relative valuation, which is a method of valuing Oasmia Pharmaceutical by comparing valuation metrics of similar companies.Oasmia Pharmaceutical is currently under evaluation in five year return category among its peers.
Oasmia Fundamentals
| Return On Equity | -0.25 | ||||
| Return On Asset | -0.0875 | ||||
| Current Valuation | 6.58 M | ||||
| Shares Outstanding | 179.35 M | ||||
| Number Of Shares Shorted | 20.72 K | ||||
| Price To Book | 0.68 X | ||||
| Price To Sales | 31.16 X | ||||
| Revenue | 26.19 M | ||||
| Gross Profit | (15.25 M) | ||||
| EBITDA | (97.54 M) | ||||
| Net Income | (132.72 M) | ||||
| Debt To Equity | 0.01 % | ||||
| Current Ratio | 6.80 X | ||||
| Cash Flow From Operations | (145.56 M) | ||||
| Short Ratio | 0.03 X | ||||
| Target Price | 6.0 | ||||
| Number Of Employees | 17 | ||||
| Beta | 0.0522 | ||||
| Market Capitalization | 21.21 M | ||||
| Total Asset | 594.31 M | ||||
| Annual Yield | 0.12 % | ||||
| Net Asset | 594.31 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.
Other Consideration for investing in Oasmia Pink Sheet
If you are still planning to invest in Oasmia Pharmaceutical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Oasmia Pharmaceutical's history and understand the potential risks before investing.
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Stocks Directory Find actively traded stocks across global markets | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges |